GSE178532 2 V 0 CISPLATIN HUMAN UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE178532 2 V 0 CISPLATIN HUMAN UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE178532 2 V 0 CISPLATIN HUMAN UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE178532 2 V 0 CISPLATIN HUMAN UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE178532 2 V 0 CISPLATIN HUMAN UP.

Results found

Linked to

 

Label

Description

 

Gene

acetylserotonin O-methyltransferase like

Gene

SRC kinase signaling inhibitor 1

Gene

synaptotagmin 15B

Gene

RAD52 motif containing 1

Gene

DIRAS family GTPase 1

Gene

dynein axonemal heavy chain 2

Gene

PHD finger protein 12

Gene

fibronectin type III and ankyrin repeat domains 1

Gene

N-alpha-acetyltransferase 40, NatD catalytic subunit

Gene

FKBP prolyl isomerase family member 15

  • Gene

    acetylserotonin O-methyltransferase like


  • Gene

    SRC kinase signaling inhibitor 1


  • Gene

    synaptotagmin 15B


  • Gene

    RAD52 motif containing 1


  • Gene

    DIRAS family GTPase 1


  • Gene

    dynein axonemal heavy chain 2


  • Gene

    PHD finger protein 12


  • Gene

    fibronectin type III and ankyrin repeat domains 1


  • Gene

    N-alpha-acetyltransferase 40, NatD catalytic subunit


  • Gene

    FKBP prolyl isomerase family member 15

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.